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Abstract 1 
Primordial germ cells (PGCs) are reprogrammed into pluripotent embryonic germ cells (EGCs) 2 
under specific culture conditions, but the detailed mechanisms of PGC reprogramming have not 3 
yet been fully clarified. Previous studies have demonstrated that AKT, an important intracellular 4 
signaling molecule, promotes reprogramming of PGCs into EGCs. Because AKT likely inhibits 5 
p53 functions to enhance PGC reprogramming, and p53 negatively regulates cell cycle 6 
progression, we analyzed cell cycle changes in PGCs following AKT activation, and found that 7 
the ratio of PGCs in the G1/G0 phase was decreased while that of PGCs in the G2/M phase was 8 
increased after AKT activation. We also showed that the expression of the CDK inhibitor p27kip1, 9 
which prevents the G1-S transition and is transcriptionally repressed by p53, was significantly 10 
down-regulated by AKT activation. The results suggested that the characteristic cell cycle 11 
changes of PGCs by AKT activation are, at least in part, due to decreased expression of p27kip1. We 12 
also investigated changes in histone H3K27 tri-methylation (H3K27me3) by AKT activation in 13 
PGCs, because we previously found that decreased H3K27me3 was involved in PGC 14 
reprogramming via upregulation of cyclin D1. We observed that AKT activation in PGCs resulted 15 
in H3K27 hypomethylation. In addition, DZNeP, an inhibitor of the H3K27 trimethyl transferase 16 
Ezh2, stimulated EGC formation. These results together suggested that AKT activation promotes 17 
G1-S transition and downregulates H3K27me3 to enhance PGC reprogramming. 18 
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Introduction 24 
During mouse embryogenesis, the fertilized egg first develops to pre-implantation blastocysts 25 
containing the inner cell mass (ICM), which is a pluripotent stem cell cluster, and further develops 26 
to epiblasts after implantation. Under specific culture conditions, the ICM can grow and give rise 27 
to pluripotent embryonic stem cells (ESCs). In early post-implantation embryos at E (embryonic 28 
day) 7.25, germ cells emerge as primordial germ cells (PGCs), which are precursors of gametes 29 
(Ginsberg et al., 1990), and are the only cells that can pass genetic information to successive 30 
generations. PGCs normally give rise only to gametes, but are also easily reprogrammed to 31 
pluripotent stem cells either under specific culture conditions (Matsui et al., 1992, Resnick et al., 32 
1992) or in specific genetic backgrounds (Stevens, 1973). PGC-derived pluripotent stem cells in 33 
culture, namely embryonic germ cells (EGCs), show similar cellular characteristics as ESCs. 34 
It previously has been reported that activation of AKT, an important intracellular signaling 35 
molecule, promotes reprogramming of PGCs to EGCs (Kimura et al., 2008). AKT functions to 36 
  3 
transmit intra-cellular signals from cytokine/growth factor receptors and affects a variety of 1 
physiological phenomena such as cell differentiation, proliferation, survival, and protein 2 
synthesis; these effects are mediated by phosphorylation of downstream target molecules (Brazil 3 
et al., 2004). In PGCs, AKT contributes to the transmission of leukemia inhibitory factor (LIF) 4 
and basic fibroblast growth factor (bFGF) signals (Kimura et al., 2008; Matsui et al., 2014). AKT 5 
may also inactivate the tumor suppressor protein p53 (Kimura et al., 2008), which generally 6 
represses cell cycle progression through transcriptional activation of genes encoding cyclin-7 
dependent kinase inhibitors (CDKIs) such as p21cip1 (El-Deiry et al., 1993). During the cell cycle, 8 
CDK4 / cyclin D and CDK2 / cyclin E complexes promote G1-S progression, while p21cip1 and 9 
p27kip1 repress G1-S transition via inhibition of the CDK / cyclin complexes (Abukhdeir and Park, 10 
2008). p21cip1 and p27kip1 are involved in mitotic arrest of PGCs and are down-regulated in Dnd1-11 
deficient germ cells in embryonic testes in the 129 genetic background (Cook et al., 2011); these 12 
Dnd1-deficient germ cells undergo reprogramming to develop into teratomas. These results 13 
together suggest that AKT activation affects cell cycle in PGCs to enhance their reprogramming. 14 
In other work, we suggested that downregulation of Ezh2, a tri-methyltransferase for histone 15 
H3 lysine (K) 27, and the subsequent decline of H3K27me3 in Dnd1-deficient germ cells in 16 
embryonic testes plays a role in the reprogramming of germ cells and teratoma development (Gu 17 
et al., 2018). We also showed that Ezh2 repressed the expression of Ccnd1 (which encodes cyclin 18 
D1) via H3K27me3, while overexpression of Ezh2 or knockdown of Ccnd1 in PGCs in culture 19 
repressed their reprogramming. Those results implied that H3K27me3 represses PGC 20 
reprogramming via cell cycle control. In the present study, we studied possible linkages between 21 
AKT activation and cell cycle / H3K27me3 changes in PGC reprogramming.  22 
 23 
 24 
Materials and methods 25 
Collecting PGCs 26 
The Oct4-ΔPE-GFP transgenic mice (Yoshimizu et al., 1999) were maintained in a C57BL/6J 27 
genetic background. Akt-Mer transgenic mice (Kimura et al., 2008) were maintained in the 28 
B6D2F1 genetic background or a mixed B6D2F1 / MCH genetic background; B6D2F1 and MCH 29 
mice were purchased from Japan SLC (Shizuoka, Japan). The mice were maintained and bred in 30 
an environmentally controlled and specific pathogen-free facility, the Animal Unit of the Institute 31 
of Development, Aging and Cancer (Tohoku University), according to the guidelines for handling 32 
of experimental animals defined by the facility. Animal protocols were reviewed and approved 33 
by the Tohoku University Animal Studies Committee. Noon on the day of the plug was defined 34 
as E0.5. Embryos of the indicated stages were obtained from female Akt-Mer transgenic mice 35 
mated with male Oct4-ΔPE-GEP transgenic mice. Embryos were collected and dissected in 36 
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Dulbecco’s modified Eagle medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA) 1 
containing 10% fetal bovine serum (FBS). The genital ridges of E12.5 embryos were dissected 2 
from individual embryos. 3 
 4 
Flow cytometry 5 
Tissue samples containing PGCs, prepared as described above, were incubated for 1 h at 37°C 6 
with 1.2 mg/ml collagenase (Sigma-Aldrich, St. Louis, MO, USA) in phosphate-buffered saline 7 
(PBS) containing 10% FBS. To prepare single-cell suspensions for flow cytometry, cells were 8 
dissociated by pipetting, and samples were filtered through a 40-μm pore nylon mesh (BD 9 
Bioscience, Bedford, MA, USA). An ALTRA (Beckman Coulter, Brea, CA, USA) or S3 (Bio-10 
Rad, Hercules, CA, USA) cell sorter was used to sort and collect PGCs with intense GFP 11 
expression. 12 
 13 
Culture of PGCs for EGC formation 14 
The sorted PGCs were cultured on a feeder layer of Sl/Sl4-m220 cells (Matsui et al., 1991) pre-15 
treated with mytomycin C in 4-well tissue culture dishes with EG medium, which was based on 16 
the previously reported GSC culture medium with modifications [StemPro34 SFM containing 17 
StemPro34 Nutrient (Thermo Fisher Scientific), 100 μg/ml transferrin (Sigma-Aldrich), 2 nM L-18 
glutamine (Thermo Fisher Scientific), 25μg/ml insulin (Sigma-Aldrich), 50 μM 2-19 
mercaptoethanol (Sigma-Aldrich), 20 ng/ml EGF (Sigma-Aldrich), 25 ng/ml human bFGF 20 
(Sigma-Aldrich), 1×103 U/ml LIF (ESGRO, Merck-Millipore, Burlingtom, MA, USA), 100 U/ml 21 
penicillin-streptomycin (Sigma-Aldrich) and 10% KSR (Thermo Fisher Scientific)] (Kanatsu-22 
Shinohara et al., 2003). After 7-9 days in culture, staining for alkaline phosphatase activity was 23 
used to identify EGC colonies, as described previously (Matsui et al., 1992). The efficiency of 24 
EGC formation was determined as a ratio of the number of EGC colonies to initially plated PGC 25 
number. 4-Hydroxytamoxifen (4OHT; Sigma-Aldrich) and 3-deazaneplanocin A hydrochloride 26 
(DZNeP; Selleck Chemicals, Houston, TX, USA) were added at 100 nM and 50 nM, respectively. 27 
For cell cycle analysis, RT-qPCR, and immunostaining, cell suspensions containing GFP-positive 28 
PGCs obtained from E12.5 embryos were cultured with or without 4OHT for 2 days. 29 
 30 
Cell cycle analysis 31 
The APC-BrdU Flow Kit (BD Bioscience) was used for estimating the per-cell amount of DNA. 32 
The kit was used according to the manufacturer’s instructions, but cells were stained only with 7-33 
amino-actinomycin D (7AAD). Flow cytometric analysis was performed using an FC500 unit 34 
(Beckman Coulter) and FlowJo software (BD Bioscience). The ratios of GFP-positive PGCs in 35 
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the G1/G0, S, and G2/M phases were estimated using the Dean-Jett-Fox model.  1 
 2 
RT-qPCR 3 
Cultured PGCs were purified by cell sorting as described above. Total RNA was purified from 4 
the sorted PGCs using an RNeasy Micro kit (Qiagen, Venlo, Netherland) and was used to 5 
synthesize cDNA. PCR was performed using Power SYBR Green master mix (Thermo Fisher 6 
Scientific) according to the manufacturer’s instructions; the primers were as shown in 7 
Supplementary Table S1. PCR signals were detected by using CFX Connect (Bio-Rad). Ppia 8 
were used as internal controls. 9 
 10 
Immunofluorescent staining of cultured PGCs 11 
Cultured PGCs were purified by cell sorting, and were adhered to microscope slides coated with 12 
aminosilane (APS). The slides were air-dried for 30 min and then fixed in 4% paraformaldehyde 13 
for 15 min at room temperature. After washing with PBS, the slides were immersed in PBST (PBS 14 
containing 0.1% Triton X-100) for 15 min at room temperature, treated for 1 h at room 15 
temperature with blocking solution (PBST containing 5% BSA), and incubated overnight at 4°C 16 
with anti-Ser473-phosphorlated AKT (pAKT) (Cell Signaling; 1:50) and anti-p27 (Santa Cruz; 17 
1:100) antibodies, or with anti-pAKT and anti-H3K27me3 (Abcam; 1:100) antibodies (diluted 18 
with the blocking solution). Cells then were washed with PBS and subsequently incubated for 1 19 
h at room temperature in blocking solution containing 1 µg/ml DAPI along with goat anti-rabbit 20 
IgG conjugated to Alexa Fluor 488 and goat anti-mouse IgG conjugated to Alexa Fluor 568. The 21 
cells again were washed with PBS and were observed under a fluorescent microscope (Leica 22 
AF6000). Fluorescence intensity for p27kip1 or H3K27me3 in pAKT-positive or -negative PGCs 23 
was quantitatively estimated by using Hybrid Cell Count Module in BZ-9000 and BZ-H2C 24 
(Keyence, Osaka, Japan). 25 
 26 
Statistical analysis 27 
Significant differences were determined using a Student’s t-test. P <0.05 was considered a 28 
statistically significant difference. 29 
 30 
 31 
Results 32 
AKT activation changes cell cycle of PGCs. 33 
We first explored whether the cell cycle of PGCs was changed by AKT activation. We isolated 34 
GFP-positive PGCs from E12.5 embryos obtained from Akt-Mer transgenic female mice (Kimura 35 
et al., 2008) mated with Oct4-ΔPE-GFP transgenic males specifically expressing GFP in PGCs 36 
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(Yoshimizu et al., 1999) (Fig. 1A), and cultured these PGCs for 24 hr with 4-hydroxy tamoxifen 1 
(4OHT) to activate the AKT-MER protein. As a control, we also cultured E12.5 PGCs of Akt-2 
Mer/Oct4-ΔPE-GFP transgenic embryos without 4OHT. We then analyzed the cell cycle of the 3 
cultured PGCs by flow cytometry, and found that cell cycle was significantly changed by AKT 4 
activation (Fig. 1B). AKT activation caused the ratio of PGCs in G1/G0 phase to decrease from 5 
34% to 24% (Fig. 1C), suggesting that the G1-S transition is enhanced by AKT activation. At the 6 
same time, the ratio of PGCs in G2/M phase increased from 31% to 46% (Fig. 1C). These results 7 
suggested that the cell cycle change of PGCs is correlated with enhanced reprogramming of PGCs 8 
by AKT activation. 9 
 10 
The expression of p27kip1 is downregulated by AKT activation 11 
We then examined the effect of AKT activation on expression of the CDK inhibitors p21cip1 and  12 
p27kip1, proteins that are known to prevent G1-S transition and likely are involved in the above-13 
mentioned cell-cycle changes. We used RT-qPCR to test the expression of p21cip1 and p27kip1 in PGCs 14 
cultured for 48 hr with or without 4OHT. This analysis showed that the expression of p27kip1, but 15 
not that of p21cip1, was significantly decreased by AKT activation (Fig. 2A). Although a previous 16 
study showed that 4OHT induced p27kip1 expression (Lee et al.,1999), its expression was not 17 
significantly increased in PGCs by 4OHT (Fig. 2B). We also performed immuno-staining of 18 
cultured PGCs using antibodies against p27kip1 and phosphorylated AKT (Ser473-pAKT). The 19 
results indicated that fluorescent intensity for p27kip1 in the Ser473-pAKT-positive (AKT-active) 20 
PGCs was significantly lower on average, than that in the Ser473-pAKT-negative (AKT-inactive) 21 
PGCs, though the intensity was varied among the cells (Fig. 3A, B). The results together suggest 22 
that AKT activation is involved in decreased expression of p27kip1, which may result in promotion 23 
of the G1-S transition in PGCs. 24 
 25 
AKT activation induces hypomethylation of H3K27 in PGCs, enhancing reprogramming. 26 
We next used immuno-staining to examine the effect of AKT activation on H3K27me3. This 27 
experiment followed from our previous demonstration that decreased H3K27me3 is involved in 28 
reprogramming PGCs to pluripotent teratoma-forming cells (Gu et al., 2018). In the present work, 29 
we examined levels of H3K27me3 by immune-staining, and found that fluorescence intensity for 30 
H3K27me3 in AKT-active PGCs was lower compared with that in AKT-inactive PGCs (Fig. 4A, 31 
B). We then investigated the effect of 3’-deazaneplanocin A (DZNeP; a known inhibitor of the 32 
H3K27 tri-methyltransferase EZH2) on formation of EGC colonies from PGCs in culture (Fig. 33 
4C). The results showed that DZNeP alone enhanced EGC formation, though the efficiency of 34 
this effect was lower than that obtained by AKT activation. These results together suggested that 35 
AKT activation-dependent enhancement of PGC reprogramming is due in part to reduced 36 
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H3K27me3. 1 
 2 
 3 
Discussion 4 
Previous studies reported that AKT activation in PGCs promoted their reprogramming, an effect 5 
that may be due, at least in part, to downregulation of p53 expression (Kimura et al., 2008). 6 
Because p53 stimulates transcription of genes negatively controlling the cell cycle, including the 7 
gene encoding the CDK inhibitor p27kip1, the present work examined the possible effects of AKT 8 
activation on cell cycle in PGCs at early stages of EGC formation. We found that the ratio of 9 
PGCs in G1/G0 was decreased (Fig.1), and the expression of p27kip1 (both at the transcriptional 10 
and translational levels) was concomitantly down-regulated, by AKT activation (Fig.2). Functions 11 
of p27kip1 are post-transcriptionally controlled by AKT in cancer cells, where nuclear translocation 12 
of phosphorylated p27kip1 by AKT is repressed (Liang et al., 2002; Shin et al., 2002), while p27kip1 13 
expression is transcriptionally repressed by AKT via phosphorylation of a Forkhead transcription 14 
factor AFX (Medema et al., 2000). In the case of PGCs, localization of p27kip1 was not affected, 15 
but both mRNA and protein of Akt were downregulated by AKT activation, suggesting 16 
involvement of transcriptional control of p27kip1. p27kip1 protein levels were varied among individual 17 
cells even without AKT activation (Fig. 3A), and it suggests that additional cell-intrinsic factors 18 
are involved in the expression of p27kip1.  19 
These results suggested that AKT activation promotes G1-S transition via downregulation of 20 
p27kip1 expression. At the same time, the ratio of PGCs in G2/M was increased by AKT activation, 21 
suggesting a slowdown in the G2-M transition, though the meaning of this effect on PGC 22 
reprogramming is currently unclear. In ESCs, the G1/S check point is missing, and length of G1 23 
phase is much shorter than that in somatic cells (Neganova and Lako, 2008). Meanwhile, the 24 
length of the G1 phase becomes longer in ESCs initiating differentiation (Kapinas et al., 2013). 25 
Differentiation generally starts in cells in the G1/G0 phase, and therefore a short G1 phase may 26 
be favorable for ESCs to maintain their undifferentiated status. Furthermore, a previous study in 27 
mouse embryonic fibroblasts (MEFs) and in granulocyte-monocyte progenitors (GMPs) 28 
demonstrated that fast-cycling cells are prone to reprogramming (Guo et al., 2014). Therefore, it 29 
is likely that a shorter G1 phase may be favorable for reprogramming. In PGCs, the shortening of 30 
the G1 phase by AKT activation may prevent differentiation of the cells and subsequent cell cycle 31 
arrest or apoptosis, which normally occur in culture; consequently, more PGCs may have a chance 32 
to undergo reprogramming. 33 
 In our previous study, we demonstrated that decreased H3K27me3 is closely correlated to 34 
conversion of germ cells into pluripotent early teratoma cells in embryonic testis, and that the 35 
H3K27 trimethytransferase EZH2 impaired the reprogramming of PGCs into pluripotent EGCs 36 
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in culture (Gu et al., 2018). In addition, EZH2 negatively regulated the expression of Ccnd1, a 1 
gene that encodes a protein (cyclin D1) that promotes G1-S transition. In the present study, we 2 
found that AKT activation diminished H3K27me3 in cultured PGCs, and confirmed that 3 
inhibition of EZH2 by DZNeP enhanced EGC formation (Fig.3). These results together suggested 4 
that activated AKT promotes reprogramming of PGCs by accelerating the G1-S transition by 5 
impeding the accumulation of p27kip1 and that of H3K27me3. In cancer cells, AKT plays a role on 6 
the expression of EZH2 (Riquelme et al., 2015), but detailed mechanisms of EZH2 upregulation 7 
are unknown. Elucidation of a mechanism whereby AKT activation decreases H3K27me3 will be 8 
an important subject for future studies. 9 
 10 
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Figure legends 32 
Figure 1. The effect of AKT activation on cell cycle in PGCs. 33 
(A) Gating of GFP-positive PGCs on flow cytometry for cell cycle analysis. Right panel shows 34 
cultured genital ridge cells of Akt-Mer × Oct4-ΔPE-GFP transgenic embryos at E12.5; left panel 35 
shows the equivalent from Akt-Mer × B6D2F1 transgenic embryos (used as a negative control 36 
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for GFP expression). (B) Cell cycle of GFP-positive PGCs cultured with or without 4OHT was 1 
examined by flow cytometry. The cells were stained with 7-amino-actinomycin D (7AAD) to 2 
permit estimation of the amount of DNA in the cells. (C) The percentage of PGCs in the G1/G0, 3 
S, and G2/M phases. The data are presented as the mean±s.e.m. of four independent experiments. 4 
*p<0.05; **p<0.001 (Student’s t test). 5 
 6 
Figure 2. Down-regulation of p27 kip1 mRNA by AKT activation in PGCs. 7 
(A) The expression of p21cip1 and p27kip1 in E12.5 PGCs obtained from Akt-Mer × Oct4-ΔPE-GFP 8 
transgenic embryos, and cultured with or without 4OHT for 2 days. (B) The expression of p27kip1 9 
in E12.5 PGCs obtained from MCH × Oct4-ΔPE-GFP transgenic embryos, and cultured with or 10 
without 4OHT for 2 days. GFP-positive PGCs were purified after culturing, and transcript levels 11 
were determined by RT-qPCR. Ppia were used as internal controls. The expression levels in PGCs 12 
cultured without 4OHT were set as 1.0. The data are presented as the mean±s.e.m. of three 13 
independent experiments. *p<0.05 (Student’s t test). 14 
 15 
Figure 3. Down-regulation of p27 kip1 protein by AKT activation in PGCs. 16 
(A) The expression of p27kip1 protein in PGCs cultured with 4OHT for 2 days. PGCs were purified 17 
after culture, and were stained with antibodies against the Ser473-phosphorylated AKT (pAKT; 18 
green) and p27kip1 (red), as well as with DAPI (blue). White arrowheads indicate pAKT signal. 19 
Scale bars: 10 µm. (B) Quantitative estimation of fluorescence intensity for p27kip1 in pAKT-20 
positive or -negative PGCs in a given field; 10 different fields were observed and fluorescence 21 
intensity of 30-200 cells in each field was measured in each experiment. The fluorescence 22 
intensities in pAkt- PGCs were set as 1.0. The data are presented as the mean±s.e.m. of three 23 
independent experiments. *p<0.05 (Student’s t test). 24 
 25 
Figure 4. Decreased H3K27 methylation following AKT activation in PGCs. 26 
(A) H3K27me3 in E12.5 PGCs cultured with 4OHT for 2 days. PGCs were purified after culturing, 27 
and were stained with the antibodies against pAKT (green) and H3K27me3 (red), as well as with 28 
DAPI (blue). White arrowheads indicate pAKT signal. Scale bars: 10 µm. (B) Quantitative 29 
estimation of fluorescence intensity for H3K27me3 in pAKT-positive or -negative PGCs in a 30 
given field; 10 different fields were observed and fluorescence intensity of 30-200 cells in each 31 
field was measured in each experiment. The fluorescence intensities in pAkt- PGCs were set as 32 
1.0. (C) The effect of DZNeP, a specific inhibitor of the H3K27 methyltransferase EZH2, on the 33 
reprogramming of PGC to EGCs. Purified E12.5 PGCs were cultured with or without 4OHT and 34 
DZNeP; 4OHT and DZNeP were added for the initial 2 days in culture. The efficiency of 35 
reprogramming is represented by ratios of EGC colony number to initially plated PGC number. 36 
  12 
The data are presented as the mean±s.e.m. of three (B) or four (C) independent experiments. 1 
*p<0.05 (Student’s t test).  2 
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